References
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC 1980
- Balthasar K. Über das anatomische Substrat der generalisierten Tic-Krankheit (Maladie destics, Gilles de la Tourette): Entwicklungshemmung des corpus striatum. Archives der Psychiatrie und Nervenkrankheiten 1957; 195: 531–549
- Borison R. L., Hamilton W. J., Nichols F. T., Diamond B. I. Trazodone and Tourette's syndrome. Neurology 1983; 33(Suppl. 2)199
- Bornstein R. A, King G., Carroll A. Neuropsychological abnormalities in Gilles de la Tourette's syndrome. The Journal of Nervous and Mental Disease 1983; 171: 497–502
- Bowers M. B., Jr. Central dopamine turnover in schizophrenia syndromes. Archives of General Psychiatry 1974; 31: 50–54
- Cohen D. J., Shaywitz B. A., Young J. G. Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette. Journal of the American Academy of Child Psychiatry 1979; 18: 320–341
- Corbett J. A., Mathews A. M., Connell P. H. Tics and Gilles de la Tourette's syndrome: A follow-up study and critical review. British Journal of Psychiatry 1969; 115: 1229–1241
- Creak M., Guttman E. Chorea, tics and compulsive utterances. Journal of mental Science 1935; 81: 836–839
- Crow T. J. Molecular pathology of schizophrenia: More than one disease concept?. British Medical Journal 1980; 280: 66–68
- Crow T. J. The biology of schizophrenia. Experientia 1982; 38: 1275–1282
- Cummings J. L., Frankel M. Gilles de la Tourette syndrome and the neurological basis of obsessions and compulsions. Biological Psychiatry 1985; 20: 1117–1126
- Elizur A., Levy A., Lahav M., Blum I. Preliminary trial of clonidine treatment in two patients suffering from chronic schizophrenia. Communications in Psychopharmacology 1980; 4: 507–517
- Fernando S. J. M. Gilles de la Tourette's syndrome: A report of four cases and a review of published case reports. British Journal of Psychiatry 1967; 113: 607–617
- Golden G. S. Tourette syndrome: Recent advances. Pediatric Neurology 1986; 2: 189–192
- Knight J. G. Dopamine receptor stimulating autoantibodies: A possible cause of schizophrenia. Lancet 1982; 2: 1073–1076
- Lucas A. R., Kauffrnan P. E., Morris E. M. Gilles de la Tourette's disease: A clinical study of fifteen cases. Journal of the American Academy of Child Psychiaty 1967; 6: 700–722
- Mettler F. A. Perceptual capacity, functions of the corpus striatum and schizophrenia. Psychiatrzc Quarterly 1955; 29: 89–111
- Sandyk R. The effects of naloxone in Tourette's syndrome. Annals of Neurology 1985; 18: 367–368
- Sandyk R., Iacono R. P. Auto-immune and post-encephalitic aspects of Tourette's syndrome and the hypothalamus. Proceedings of the Annual Child Neurology Society 1986, No. 268
- Shapiro A. K., Shapiro E., Wayne H. The psychopathology of Gilles de la Tourette's syndrome. American Journal of Psychiarry 1972; 129: 427–434
- Shelley R. K., Waksh N. The biochemistry of schizophrenia—A review. Irish medical Journal 1985; 78: 139–143
- Snyder S. Schizophrenia. Lancet 1982; I: 970–974
- Takeuchi K., Tamashita M., Morikyo M., Takeda N., Morita K., Tarnura T., Kaiya H. Gilles de la Tourette's syndrome and schizophrenia. The Journal of Nervous and Mental Disease 1986; 174: 247–248
- Wyatt R. J., Waughan T., Galanter M., Kaplan J., Green R. Behavioral changes of chronic schizophrenic patients given L-5-hydroxtryptophan. Science 1972; 177: 1124–1126